The reference here has nothing to do with the Pulitzer-winning book of Alice Walker, but the actual colour that has pushed big pharma to pu...

Following the acquisition, the Ranbaxy brand will cease to exist and both the companies will be operated under one management.

While it’s still too early to say how Infosys buying Lodestone will play out, there are some immediately visible benefits. We list five of ...

Cipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...

In a candid conversation, Dr Reddy’s Laboratories’ vice-chairman and MD, GV Prasad, talks about the strengths and weaknesses of the domesti...

Novartis has recognised the growth potential of rural India early on. ET caught up with Olivier Jarry, senior vice president (strategy and ...